**Objective.β** Gastrointestinal symptoms, such as nausea and vomiting, occur almost universally at one time or another in patients during a migraine attack. One third of patients who experience migraineβrelated nausea report that this symptom interferes with their ability to take oral medications.
A Sumatriptan Iontophoretic Transdermal System for the Acute Treatment of Migraine
β Scribed by Jerome Goldstein; Timothy R. Smith; Neil Pugach; Jim Griesser; Terri Sebree; Mark Pierce
- Book ID
- 114746973
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 415 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0017-8748
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Migraine is a common, multisymptom disorder that can severely impact the daily activities of migraineurs. Triptans (primarily sumatriptan) are the most commonly prescribed treatment for migraine and are considered a relatively safe and effective initial therapy. Unfortunately, current sumatriptan fo
We have successfully obtained sumatriptan transdermal systems with different polymer compositions: methyl cellulose (MC), polyvinyl pyrrolidone (PVP) and a polyvinyl pyrrolidone (PVP)-polyvinyl alcohol (PVA) mixture. The systems contained 1,2-propylenglycol (MC) or sorbitol as a plasticizer (PVP and